Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

The diagnosis of scabies by non-expert examiners: A study of diagnostic accuracy.

Osti MH, Sokana O, Gorae C, Whitfeld MJ, Steer AC, Engelman D.

PLoS Negl Trop Dis. 2019 Aug 19;13(8):e0007635. doi: 10.1371/journal.pntd.0007635. [Epub ahead of print]

2.

The Limitations of the Rheumatogenic Concept for Group A Streptococcus: Systematic Review and Genetic Analysis.

de Crombrugghe G, Baroux N, Botteaux A, Moreland NJ, Williamson DA, Steer AC, Smeesters PR.

Clin Infect Dis. 2019 Jul 23. pii: ciz425. doi: 10.1093/cid/ciz425. [Epub ahead of print]

PMID:
31334754
3.

Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, DuchĂȘne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Aug;51(8):1295. doi: 10.1038/s41588-019-0482-z.

PMID:
31324894
4.

Mass Drug Administration for Scabies - 2 Years of Follow-up.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Andrews RM, Kaldor JM, Steer AC.

N Engl J Med. 2019 Jul 11;381(2):186-187. doi: 10.1056/NEJMc1808439. Epub 2019 Jun 26. No abstract available.

PMID:
31242358
5.

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.

Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, Fischer PU, Goss CW, Hardy M, Jambulingam P, King CL, Kuttiat VS, Krishnamoorthy K, Laman M, Lemoine JF, O'Brian KK, Robinson LJ, Samuela J, Schechtman KB, Sircar A, Srividya A, Steer AC, Supali T, Subramanian S; DOLF IDA Safety Study Group.

PLoS Med. 2019 Jun 24;16(6):e1002839. doi: 10.1371/journal.pmed.1002839. eCollection 2019 Jun.

6.

The public health control of scabies: priorities for research and action.

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC.

Lancet. 2019 Jul 6;394(10192):81-92. doi: 10.1016/S0140-6736(19)31136-5. Epub 2019 Jun 6. Review.

PMID:
31178154
7.

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, DuchĂȘne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Jun;51(6):1035-1043. doi: 10.1038/s41588-019-0417-8. Epub 2019 May 27. Erratum in: Nat Genet. 2019 Jul 19;:.

PMID:
31133745
8.

Prevalence of scabies and impetigo three years after mass drug administration with ivermectin and azithromycin.

Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC.

Clin Infect Dis. 2019 May 25. pii: ciz444. doi: 10.1093/cid/ciz444. [Epub ahead of print]

9.

Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.

Osowicki J, Azzopardi KI, Baker C, Waddington CS, Pandey M, Schuster T, Grobler A, Cheng AC, Pollard AJ, McCarthy JS, Good MF, Walker MJ, Dale JB, Batzloff MR, Carapetis JR, Smeesters PR, Steer AC.

Vaccine. 2019 Jun 6;37(26):3485-3494. doi: 10.1016/j.vaccine.2019.03.059. Epub 2019 May 14.

PMID:
31101422
10.

Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.

Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Cordell B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC.

Lancet Infect Dis. 2019 May;19(5):510-518. doi: 10.1016/S1473-3099(18)30790-4. Epub 2019 Apr 4.

11.

Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease.

Macleod CK, Bright P, Steer AC, Kim J, Mabey D, Parks T.

Trans R Soc Trop Med Hyg. 2019 May 1;113(5):287-290. doi: 10.1093/trstmh/trz014.

12.

Systematic Review of Group A Streptococcal emm Types Associated with Acute Post-Streptococcal Glomerulonephritis.

Worthing KA, Lacey JA, Price DJ, McIntyre L, Steer AC, Tong SYC, Davies MR.

Am J Trop Med Hyg. 2019 May;100(5):1066-1070. doi: 10.4269/ajtmh.18-0827.

PMID:
30915958
13.

A Controlled Human Infection Model of Group A Streptococcus Pharyngitis: Which Strain and Why?

Osowicki J, Azzopardi KI, McIntyre L, Rivera-Hernandez T, Ong CY, Baker C, Gillen CM, Walker MJ, Smeesters PR, Davies MR, Steer AC.

mSphere. 2019 Feb 13;4(1). pii: e00647-18. doi: 10.1128/mSphere.00647-18.

14.

The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics.

Vekemans J, Gouvea-Reis F, Kim JH, Excler JL, Smeesters PR, O'Brien KL, Van Beneden CA, Steer AC, Carapetis JR, Kaslow DC.

Clin Infect Dis. 2019 Aug 16;69(5):877-883. doi: 10.1093/cid/ciy1143.

15.

Exploration of a simplified clinical examination for scabies to support public health decision-making.

Marks M, Engelman D, Romani L, Mason D, Sokana O, Kama M, Whitfeld M, Steer AC, Kaldor J.

PLoS Negl Trop Dis. 2018 Dec 27;12(12):e0006996. doi: 10.1371/journal.pntd.0006996. eCollection 2018 Dec.

16.

Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review.

May PJ, Tong SYC, Steer AC, Currie BJ, Andrews RM, Carapetis JR, Bowen AC.

Trop Med Int Health. 2019 Mar;24(3):280-293. doi: 10.1111/tmi.13198. Epub 2019 Jan 28.

17.

Scabies: New Opportunities for Management and Population Control.

Thean LJ, Engelman D, Kaldor J, Steer AC.

Pediatr Infect Dis J. 2019 Feb;38(2):211-213. doi: 10.1097/INF.0000000000002211. No abstract available.

PMID:
30299425
18.

Control Strategies for Scabies.

Engelman D, Steer AC.

Trop Med Infect Dis. 2018 Sep 5;3(3). pii: E98. doi: 10.3390/tropicalmed3030098. Review.

19.

Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.

Coscione S, Esau T, Kekeubata E, Diau J, Asugeni R, MacLaren D, Steer AC, Kositz C, Marks M.

PLoS Negl Trop Dis. 2018 Sep 25;12(9):e0006825. doi: 10.1371/journal.pntd.0006825. eCollection 2018 Sep.

20.

Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.

Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Steer AC, Kaldor JM.

Lancet Glob Health. 2018 Oct;6(10):e1132-e1138. doi: 10.1016/S2214-109X(18)30397-8. Erratum in: Lancet Glob Health. 2019 Feb;7(2):e190.

Supplemental Content

Loading ...
Support Center